Spotlight Therapeutics Closes $30 Million Series A to Advance CRISPR Technology

https://endpts.com/scoop-googles-gv-spearheads-the-spotlight-syndicate-backing-an-upstart-biotech-aimed-at-democratizing-gene-editing/
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.